Pain, Substance Use Disorders and Opioid Analgesic Prescription Patterns in Veterans with Hepatitis C

Journal of Pain and Symptom Management

Volumn 36, Issue 1, 2008, Pages 39-45

  Whitehead, Ashlee J ^a,b   Dobscha, Steven K ^b,c,e   Morasco, Benjamin J ^a,b,e   Ruimy, Samantha ^a,b   Bussell, Cara ^a,b   Hauser, Peter ^a,b,d,e,f  

^a Northwest Hepatitis C Resource Center

^b Behavioral Health and Clinical Neurosciences Division

^c Comorbid Mental and Physical Disorders ^*

^d PORTLAND VA MEDICAL CENTER   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

hepatitis C; medication misuse; Opioids; pain management; veterans

Indexed keywords

ALCOHOL; AMPHETAMINE; ANALGESIC AGENT; CANNABIS; COCAINE; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; MORPHINE; OPIATE; OXYCODONE; PSYCHEDELIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; POLYMERASE CHAIN REACTION; PREVALENCE; SUBSTANCE ABUSE; VETERAN;

ANALGESICS, OPIOID; COMORBIDITY; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PAIN; PRESCRIPTIONS, DRUG; PREVALENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 45849101744     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2007.08.013     Document Type: Article

References (34)

1. Dominitz J.A., Boyko E.J., Koepsell T.D., et al. Elevated prevalence of hepatitis C infection in users of United States Veterans medical centers. Hepatology 41 1 (2005) 88-96
2. Armstrong G.L., Wasley A., Simard E.P., et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 10 (2006) 705-714
3. Poynard T., Cacoub P., Ratziu V., et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat 9 4 (2002) 295-303
4. Vassilopoulos D., and Calabrese L.H. Rheumatic manifestations of hepatitis C infection. Curr Rheumatol Rep 5 3 (2003) 200-204
5. Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol 12 4 (2000) 295-299
6. Cacoub P., Poynard T., Ghillani P., et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 42 10 (1999) 2204-2212
7. Sterling R.K., and Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 8 1 (2006) 53-59
8. Barkhuizen A., Rosen H.R., Wolf S., et al. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol 94 5 (1999) 1355-1360
9. Ballantyne J.C., and Mao J. Opioid therapy for chronic pain. N Engl J Med 349 20 (2003) 1943-1953
10. Caudill-Slosberg M.A., Schwartz L.M., and Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 109 3 (2004) 514-519
11. Clark J.D. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 23 2 (2002) 131-137
12. McQuay H. Opioids in pain management. Lancet 353 9171 (1999) 2229-2232
13. Bloodworth D. Issues in opioid management. Am J Phys Med Rehabil 84 3 Suppl (2005) S42-S55
14. Zdilar D., Franco-Bronson K., Buchler N., Locala J.A., and Younossi Z.M. Hepatitis C, interferon alfa, and depression. Hepatology 31 6 (2000) 1207-1211
15. Loftis J.M., Matthews A.M., and Hauser P. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs 66 2 (2006) 155-174
16. Sylvestre D.L., Loftis J.M., Hauser P., et al. Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health 81 4 (2004) 719-734
17. Fireman M., Indest D.W., Blackwell A., Whitehead A.J., and Hauser P. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis 15 40 Suppl. 5 (2005) S286-S291
18. Huckans M.S., Blackwell A.D., Harms T.A., Indest D.W., and Hauser P. Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection. AIDS 19 Suppl. 3 (2005) S106-S115
19. el-Serag H.B., Kunik M., Richardson P., and Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 123 2 (2002) 476-482
20. Seeff L.B., and Hoofnagle J.H. National Institutes of Health consensus development conference: management of hepatitis C: 2002. Hepatology 36 5 Suppl. 1 (2002) S1-S2
21. Schiff E.R. Hepatitis C and alcohol. Hepatology 26 3 Suppl. 1 (1997) 39S-42S
22. Cohen M.J., Jasser S., Herron P.D., and Margolis C.G. Ethical perspectives: opioid treatment of chronic pain in the context of addiction. Clin J Pain 18 4 Suppl (2002) S99-S107
23. Collins E.D., and Streltzer J. Should opioid analgesics be used in the management of chronic pain in opiate addicts?. Am J Addict 12 2 (2003) 93-100
24. Gilson A.M., and Joranson D.E. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain 18 4 Suppl (2002) S91-S98
25. Rosenblum A., Joseph H., Fong C., et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 289 18 (2003) 2370-2378
26. Savage S.R. Assessment for addiction in pain-treatment settings. Clin J Pain 18 4 Suppl (2002) S28-S38
27. Riley III T.R., and Bhatti A.M. Preventive strategies in chronic liver disease: part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise. Am Fam Physician 64 9 (2001) 1555-1560
28. Li Y., Zhang T., Douglas S.D., et al. Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 163 3 (2003) 1167-1175
29. Kotb H.I., el-Kabsh M.Y., Emara S.E., and Fouad E.A. Pharmacokinetics of controlled release morphine (MST) in patients with liver cirrhosis. Br J Anaesth 79 6 (1997) 804-806
30. Potter M., Schafer S., Gonzalez-Mendez E., et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract 50 2 (2001) 145-151
31. Kirsh K.L., Whitcomb L.A., Donaghy K., and Passik S.D. Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain 18 4 Suppl (2002) S52-S60
32. Passik S.D., Kirsh K.L., Donaghy K.B., and Portenoy R.K. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain 22 2 (2006) 173-181
33. Portenoy R.K. Opioid therapy for chronic nonmalignant pain. Pain Res Manag 1 1 (1996) 17-28
34. Robinson R.C., Gatchel R.J., Polatin P., et al. Screening for problematic prescription opioid use. Clin J Pain 17 3 (2001) 220-228